Prediction of effect of a c-Met inhibitor using mutation of KRAS or BRAF
Abstract:
A method for predicting and/or monitoring the efficacy of a c-Met inhibitor using a biomarker; a method for selecting a subject suitable for the application of a c-Met inhibitor using a biomarker; and a method for preventing and/or treating cancer comprising administering a c-Met inhibitor to the selected subject.
Information query
Patent Agency Ranking
0/0